122 related articles for article (PubMed ID: 36602811)
1. Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
Carroll CE; Landrum MB; Wright AA; Keating NL
JAMA Oncol; 2023 Mar; 9(3):324-333. PubMed ID: 36602811
[TBL] [Abstract][Full Text] [Related]
2. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
3. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.
Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
[TBL] [Abstract][Full Text] [Related]
4. Association of Oncologist Participation in Medicare's Oncology Care Model With Patient Receipt of Novel Cancer Therapies.
Manz CR; Tramontano AC; Uno H; Parikh RB; Bekelman JE; Schrag D
JAMA Netw Open; 2022 Sep; 5(9):e2234161. PubMed ID: 36173630
[TBL] [Abstract][Full Text] [Related]
5. Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients.
Dean EB; Johnson P; Bond AM
JAMA Netw Open; 2021 Jan; 4(1):e2034776. PubMed ID: 33502485
[TBL] [Abstract][Full Text] [Related]
6. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US.
Kerekes DM; Frey AE; Prsic EH; Tran TT; Clune JE; Sznol M; Kluger HM; Forman HP; Becher RD; Olino KL; Khan SA
JAMA Oncol; 2024 Mar; 10(3):342-351. PubMed ID: 38175659
[TBL] [Abstract][Full Text] [Related]
8. Use of Clinicians Who Focus on Nursing Home Care Among US Nursing Homes and Unplanned Rehospitalization.
Kim S; Ryskina KL; Jung HY
JAMA Netw Open; 2023 Jun; 6(6):e2318265. PubMed ID: 37314803
[TBL] [Abstract][Full Text] [Related]
9. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
[TBL] [Abstract][Full Text] [Related]
10. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Reliability and Correlations of Quality Measures in Cancer Care.
Keating NL; Cleveland JLF; Wright AA; Brooks GA; Meneades L; Riedel L; Zubizarreta JR; Landrum MB
JAMA Netw Open; 2021 Mar; 4(3):e212474. PubMed ID: 33749769
[TBL] [Abstract][Full Text] [Related]
13. Association of Rurality, Race and Ethnicity, and Socioeconomic Status With the Surgical Management of Colon Cancer and Postoperative Outcomes Among Medicare Beneficiaries.
Ramkumar N; Colla CH; Wang Q; O'Malley AJ; Wong SL; Brooks GA
JAMA Netw Open; 2022 Aug; 5(8):e2229247. PubMed ID: 36040737
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Rural-Urban Differences in Postacute Care Utilization and Outcomes Among Older US Adults.
Kosar CM; Loomer L; Ferdows NB; Trivedi AN; Panagiotou OA; Rahman M
JAMA Netw Open; 2020 Jan; 3(1):e1918738. PubMed ID: 31913495
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Rural-Urban Differences in Health Care Use and Survival Among Medicare Beneficiaries With Alzheimer Disease and Related Dementia.
Rahman M; White EM; Thomas KS; Jutkowitz E
JAMA Netw Open; 2020 Oct; 3(10):e2022111. PubMed ID: 33090226
[TBL] [Abstract][Full Text] [Related]
16. Association of the Comprehensive Care for Joint Replacement Model With Disparities in the Use of Total Hip and Total Knee Replacement.
Thirukumaran CP; Kim Y; Cai X; Ricciardi BF; Li Y; Fiscella KA; Mesfin A; Glance LG
JAMA Netw Open; 2021 May; 4(5):e2111858. PubMed ID: 34047790
[TBL] [Abstract][Full Text] [Related]
17. Association Between a Bundled Payment Program for Lower Extremity Joint Replacement and Patient Outcomes Among Medicare Advantage Beneficiaries.
Sutherland A; Boudreau E; Bowe A; Huang Q; Liao JM; Flagg M; Cousins D; Antol DD; Shrank WH; Powers BW; Navathe AS
JAMA Health Forum; 2023 Jun; 4(6):e231495. PubMed ID: 37355996
[TBL] [Abstract][Full Text] [Related]
18. Mapping the Diffusion of Technology in Orthopaedic Surgery: Understanding the Spread of Arthroscopic Rotator Cuff Repair in the United States.
Austin DC; Torchia MT; Lurie JD; Jevsevar DS; Bell JE
Clin Orthop Relat Res; 2019 Nov; 477(11):2399-2410. PubMed ID: 31393337
[TBL] [Abstract][Full Text] [Related]
19. Comparison of US Oncologist Rurality by Practice Setting and Patients Served.
Cornelius SL; Shaefer AP; Wong SL; Moen EL
JAMA Netw Open; 2024 Jan; 7(1):e2350504. PubMed ID: 38180759
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries.
Green AK; Curry M; Trivedi N; Bach PB; Mailankody S
JAMA Netw Open; 2021 Feb; 4(2):e210030. PubMed ID: 33625507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
